Bioavailability Of Sublingual Buprenorphine - PubMed
Maybe your like
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- Grants and funding
- LinkOut - more resources
Abstract
Buprenorphine administered sublingually is a promising treatment for opiate dependence. Utilizing a new, sensitive, and specific gas chromatographic electron-capture detector assay, the absolute bioavailability of sublingual buprenorphine was determined in six healthy volunteers by comparing plasma concentrations after 3- and 5-minute exposures to 2 mg sublingual and 1 mg intravenous buprenorphine. The amount of unabsorbed buprenorphine in saliva was measured after 2-, 4-, and 10-minute exposures to 2 mg sublingual buprenorphine in 12 participants. Pharmacokinetic parameters were analyzed by analysis of variance; bioequivalence was evaluated by the Schuirmann two-sided test. The 3- and 5-minute sublingual exposures each allowed 29 +/- 10% bioavailability (area under the plasma concentration-time curve unextrapolated) and were bioequivalent. Buprenorphine recovered from saliva after 2-, 4-, and 10-minute exposures was, on average, 52% to 55% of dose. Increased saliva pH was correlated with decreased recovery from saliva. Study results indicate that bioavailability of sublingual buprenorphine is approximately 30%. Sublingual exposure times between 3 and 5 minutes produce equivalent results. Buprenorphine remaining in saliva causes an almost twofold overestimation of bioavailability.
PubMed Disclaimer
Publication types
- Research Support, U.S. Gov't, P.H.S. Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Administration, Sublingual Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Adult Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Analgesics, Opioid / administration & dosage Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Analgesics, Opioid / pharmacokinetics* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Analysis of Variance Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Biological Availability Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Buprenorphine / administration & dosage Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Buprenorphine / pharmacokinetics* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Injections, Intravenous Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Middle Aged Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Opioid-Related Disorders / prevention & control* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Saliva Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Analgesics, Opioid Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Buprenorphine Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Grants and funding
- 271-90-7307/PHS HHS/United States
- DA00053/DA/NIDA NIH HHS/United States
- DA01696/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Tag » How To Maximize Suboxone Absorption
-
How The Suboxone Spit Trick Works - Confidant Health
-
How To Maximize Suboxone Absorption - Confidant Health
-
How Can I Make Suboxone Absorb Better? - Bicycle Health
-
How Do I Maximize Suboxone Absorption?
-
How To Take A Suboxone Pill To Get The Highest Absorption - Quora
-
Improving The Oral Bioavailability Of Buprenorphine: An In-vivo Proof ...
-
Reconsidering The Usefulness Of Adding Naloxone To Buprenorphine
-
Buprenorphine/naloxone (Suboxone) Home Dosing: Rapid 2-day ...
-
Is Swallowing Suboxone Okay? What To Know - MATClinics
-
Maximizing Bioavailability Of Suboxone Films? - Reddit
-
How Should I Take Suboxone For Max Absorption? - Reddit
-
Different Ways To Take Suboxone - Direct2Recovery
-
Buprenorphine With Naloxone (Suboxone Sublingual Film) For Opiate ...